Wilmington Savings Fund Society’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75K Buy
9
+1
+13% +$207 ﹤0.01% 1356
2026
Q1
$1.8K Hold
8
﹤0.01% 1359
2025
Q4
$1.93K Hold
8
﹤0.01% 1319
2025
Q3
$2.19K Sell
8
-1,652
-100% -$451K ﹤0.01% 1299
2025
Q2
$428K Buy
1,660
+271
+20% +$64.6K 0.01% 618
2025
Q1
$311K Buy
1,389
+501
+56% +$117K 0.01% 691
2024
Q4
$203K Buy
888
+99
+13% +$23.8K ﹤0.01% 822
2024
Q3
$193K Buy
+789
New +$176K ﹤0.01% 829

Other funds holding RMD

Wilmington Savings Fund Society's RMD Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its ResMed (RMD) stake by 13% in Q2 2026, buying an estimated $207 and bringing the position to 9 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Wilmington Savings Fund Society first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $428K in Q2 2025. 279 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wilmington Savings Fund Society held 9 shares of ResMed worth $1.75K as of Q2 2026.
  • Wilmington Savings Fund Society bought 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1356 holding.
  • Wilmington Savings Fund Society first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's ResMed position peaked at $428K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.